One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor

BACKGROUND: We determined the frequency of and factors associated with ≥10% weight gain and its metabolic effects in virally suppressed people with human immunodeficiency virus (PWH) from the Dutch national AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort switching to tenofovir alafenamide...

Descripción completa

Detalles Bibliográficos
Autores principales: Verburgh, Myrthe L, Wit, Ferdinand W N M, Boyd, Anders, Verboeket, Sebastiaan O, Reiss, Peter, van der Valk, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301581/
https://www.ncbi.nlm.nih.gov/pubmed/35873291
http://dx.doi.org/10.1093/ofid/ofac291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301581/
https://www.ncbi.nlm.nih.gov/pubmed/35873291
http://dx.doi.org/10.1093/ofid/ofac291

Ejemplares similares